« Back
Home /
Crizanlizumab Biosimilar(Anti-P-Selectin / CD62p Reference Antibody)

Crizanlizumab Biosimilar(Anti-P-Selectin / CD62p Reference Antibody)

Item no.	DCC-A943-100mg
Manufacturer	DCChemicals
CASRN	1690318-25-2
Amount	100 mg
Category	Neuroscience Neural Signaling Neural Adhesion Molecules
Specific against	other
Available
Manufacturer - Applications	Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer